Haughney, JohnLee, Amanda J.Nath, MintuMüllerová, HanaHolmgren, UlfNigris, Enrico deDing, Bo2022-03-072022-03-072022Haughney, J, Lee, A J, Nath, M, Müllerová, H, Holmgren, U, Nigris, E D & Ding, B 2022, 'The long-term clinical impact of COPD exacerbations : a 3-year observational study (SHERLOCK)', Therapeutic advances in respiratory disease, vol. 16, 17534666211070139. https://doi.org/10.1177/175346662110701391753-4658ORCID: /0000-0002-4865-9061/work/159078030ORCID: /0000-0002-0753-0464/work/161797526https://hdl.handle.net/2164/18169Acknowledgements Medical writing support, under the direction of the authors, was provided by Sara Cameron, M. Phil., of CMC Connect, McCann Health Medical Communications, funded by AstraZeneca in accordance with Good Publication Practice (GPP3) guidelines. The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by AstraZeneca. Employees of AstraZeneca were involved in the design of the study, interpretation of the data (but not the data collection), in the writing of the report, and in the decision to submit the article for publication.10506383engchronic obstructive pulmonary diseaseexacerbationsriskR MedicinePulmonary and Respiratory MedicinePharmacology (medical)Supplementary InformationRJournal article10.1177/17534666211070139http://www.scopus.com/inward/record.url?scp=85124587676&partnerID=8YFLogxK16